How should placenta previa be managed before 28 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Placenta Previa Before 28 Weeks Gestation

Before 28 weeks, women with placenta previa should undergo serial ultrasound surveillance with transabdominal and transvaginal imaging plus Doppler to assess for placenta accreta spectrum disorder (PASD), particularly if they have prior cesarean delivery or uterine surgery, while asymptomatic patients can be managed as outpatients with activity modifications. 1

Imaging Surveillance Strategy

Initial Diagnostic Approach

  • Perform comprehensive transabdominal ultrasound to visualize the placenta, inferior placental margin, placental umbilical cord insertion, and cervix from external to internal os 1
  • Add transvaginal ultrasound for detailed evaluation of the placental-myometrial interface and bladder interface, especially when the placenta is near the lower uterine segment 1
  • Include Duplex Doppler imaging to detect increased placental vascular flow, subplacental vascularity, and vessels at the bladder-uterine interface—critical markers for PASD 1

Timing Considerations for Advanced Imaging

  • MRI before 24 weeks has unacceptable accuracy with poor sensitivity and positive predictive values for PASD 1
  • If ultrasound findings before 24 weeks are severely abnormal and suggest placenta percreta, consider early MRI to confirm disease extent for counseling about preterm delivery risk and delivery planning 1
  • Optimal MRI timing is 30-35 weeks gestation if needed, though follow-up imaging at 28-32 weeks is recommended per Society for Maternal-Fetal Medicine guidelines 1

Risk Stratification for PASD

High-Risk Features Requiring Enhanced Surveillance

  • Prior cesarean delivery increases PASD risk 7-fold after one cesarean to 56-fold after three cesareans 1
  • Placenta previa overlying a uterine scar or low-lying over the scar mandates early third trimester follow-up at 28-32 weeks 1
  • Look for ultrasound markers: placental lacunae, loss of retroplacental clear space, myometrial thinning <1mm, placental bulging, and abnormal color Doppler patterns 1

Clinical Pitfall

Only 70% of PASD cases are identified antenatally despite risk factors being present, so maintain high clinical suspicion even with initially reassuring imaging 1

Activity and Location Management

Asymptomatic Patients

  • Outpatient management is safe and cost-effective for asymptomatic women before 28 weeks 2
  • Avoid moderate-to-vigorous physical activity (running, heavy lifting, vigorous exercise) but continue activities of daily living and low-intensity walking 3
  • Implement pelvic rest: no vaginal intercourse or vaginal insertion 3
  • Travel is not contraindicated as long as patients remain within reasonable proximity to an obstetric facility capable of emergent cesarean delivery 3

Symptomatic Patients (Prior Bleeding)

  • Brief hospitalization with tocolysis may help stop bleeding episodes before 34 weeks 4
  • After stabilization for ≥72 hours, outpatient management is acceptable with weekly follow-up 2
  • Recurrent bleeding occurs in 62% of cases, requiring readmission and potential expeditious delivery 2
  • Consider hospitalization if bleeding is significant, as these patients have increased risk of subsequent hemorrhage 3

Serial Monitoring Protocol

Frequency of Surveillance

  • Asymptomatic patients: Follow-up ultrasound at 6-8 week intervals until delivery or unequivocal conversion 5
  • Symptomatic patients: Weekly or biweekly ultrasound cervical length and placental edge thickness measurements to predict antepartum bleeding 1
  • High-risk for PASD: Serial scans starting at 28 weeks to assess depth of invasion and plan surgical approach 1

What to Monitor

  • Distance from internal cervical os to placental edge: Document whether placenta overlaps the os and by how much 1
  • Progression of PASD markers: Interval change in myometrial thinning, placental bulging, and subplacental hypervascularization 1
  • Cervical changes and fetal growth: Assess for preterm labor risk and appropriate fetal development 1

Conversion Expectations

90% of placenta previa diagnosed at 16-18 weeks will convert to normal placentation by delivery 5. However:

  • No activity restrictions are indicated unless placenta previa persists beyond 30 weeks or becomes clinically manifest with bleeding 5
  • Continue surveillance as conversion can occur throughout pregnancy, though persistence beyond 30 weeks increases likelihood of previa at delivery 5

Red Flags Requiring Immediate Hospitalization

  • Active vaginal bleeding 3
  • Preterm labor 3
  • Preterm premature rupture of membranes 3
  • Signs of hemodynamic instability or need for blood transfusion 2

Coordination of Care

Patients with placenta previa overlying a cesarean scar should be referred to tertiary centers where multidisciplinary teams experienced in managing PASD are available for both scheduled and emergent delivery 1. This is critical because undiagnosed PASD at delivery significantly increases maternal morbidity and mortality 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Activity and Travel Recommendations for Placenta Previa after 28 Weeks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Management of placenta previa and accreta].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2014

Research

Natural history of placenta previa ascertained by diagnostic ultrasound.

American journal of obstetrics and gynecology, 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.